Summit Therapeutics Inc. logo SMMT - Summit Therapeutics Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 14
HOLD 7
SELL 0
STRONG
SELL
0
| PRICE TARGET: $19.00 DETAILS
HIGH: $23.00
LOW: $16.00
MEDIAN: $18.00
CONSENSUS: $19.00
UPSIDE: 14.32%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Revenue
Revenue 0 0 0 0.6 1.3 0.6 0.6 57.1 14.2 2.4 1.3 1.9 2.3 2.9 1.8 1.2 0.3 0.3 6.0 2.0 0.9 0.2 0.0
Cost of Revenue 0 0 0 0 0 0 0 0.0 0 0 0.1 0 0.0 0.1 0.2 0.4 2.3 0.0 3.2 0.6 0.4 0.2 0.0
Gross Profit 0 0 0 0.6 1.3 0.6 0.6 56.4 14.2 2.4 1.3 1.9 1.8 1.9 1.6 1.2 (2.1) 0.3 0.1 1.4 0.5 0.0 0
Operating Expenses
R&D Expenses 537.7 132.4 455.3 43.0 63.1 39.0 32.8 49.1 29.0 19.0 16.9 10.4 6.6 4.7 3.1 2.2 3.7 7.4 15.3 5.8 1.8 0.5 0.0
SG&A Expenses 556.7 48.3 23.7 22.1 17.5 14.1 9.3 17.0 11.9 8.3 4.8 3.7 1.9 1.7 1.5 1.7 4.2 1.1 2.2 1 1.8 0.1 0.0
Other Expenses 0 (0.3) (0.8) (4.9) (15.5) (13.5) (18.8) (14.4) (0.9) 0 0 0 0 0 0 0 (4.2) 6.2 8.7 3.2 0.1 0 (0.0)
Operating Expenses 1,094.4 180.5 478.2 60.2 65.1 39.5 23.2 51.7 40.0 27.2 21.6 14.1 8.6 6.5 4.6 4.0 3.7 14.7 26.2 10.0 3.7 0.6 0.0
Operating Income
Operating Income (1,094.4) (180.5) (478.2) (59.6) (63.7) (38.9) (22.6) 5.4 (25.8) (24.9) (20.3) (12.2) (6.7) (4.6) (4.7) (9.4) (9.2) (19.2) (23.4) (8.6) (3.2) (0.5) (0.0)
Interest Expense 0 8.7 16.5 4.4 0.2 0.3 0.0 0.6 0 1.1 0 0.4 0 0 0.0 0.0 0.1 0.1 0.1 0.0 0 0 0
Interest Income 0 13.5 10.4 1.5 0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.5 1.7 1.0 0.4 0.0
Profitability
EBITDA (1,079.4) (168.5) (69.5) (51.6) (62.7) (37.1) (21.6) 11.7 (26.3) (24.8) (20.3) (12.2) (11.0) (7.1) (4.4) (8.6) (5.4) (16.0) (18.6) (6.1) (3.0) (0.5) (0.0)
EBIT (1,079.5) (168.5) (69.6) (52.6) (63.7) (38.3) (22.6) 9.7 (26.7) (24.9) (20.3) (12.2) (11.1) (7.2) (4.7) (9.4) (9.2) (18.8) (21.9) (6.9) (3.2) (0.5) (0.1)
Income Before Tax (1,079.5) (176.8) (482.4) (65.2) (65.5) (38.7) (24.0) 9.1 (23.9) (25.7) (23.2) (12.7) (6.7) (4.6) (4.7) (9.4) (9.3) (18.9) (21.9) (6.9) (2.2) (0.1) (0.0)
Income Tax Expense 0 0 0 0 0 0.2 0.0 (1.8) 3.8 4.3 (3.3) (1.4) (1.0) (0.5) (0.5) (1.9) (0.6) (2.5) (1.8) (1.0) (0.3) (0.0) 0
Net Income (1,079.6) (176.8) (482.4) (65.2) (65.5) (38.5) (24.0) 10.9 (20.2) (21.4) (24.3) (17.1) (6.1) (6.7) (4.2) (7.4) (5.3) (32.3) (20.1) (5.9) (1.9) (0.1) (0.0)
Per Share Data
EPS (Basic) -1.44 -0.25 -0.78 -0.34 -0.71 -0.55 -0.73 0.11 -0.31 -0.35 -0.34 -0.31 -0.34 -0.42 -0.36 -0.19 -0.13 -0.60 -0.42 -0.16 -0.06 -0.00 -0.00
EPS (Diluted) -1.44 -0.25 -0.78 -0.34 -0.71 -0.56 -0.73 0.11 -0.31 -0.35 -0.34 -0.31 -0.34 -0.42 -0.36 -0.19 -0.13 -0.60 -0.42 -0.16 -0.06 -0.00 -0.00
Shares Outstanding 747.7 713.9 619.6 192.2 92.2 69.3 32.7 86.1 65.0 61.1 59.1 39.6 29.4 15.8 11.6 38.2 67.0 53.4 47.9 36.4 31.3 23.5 19.0
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003
Current Assets
Cash & Cash Equivalents 167.2 83.8 56.5 284.2 53.2 48.8 50.0 35.2 28.5 35.1 9.7 3.9 26.7 0.1
Short-Term Investments 362.3 245.7 90.9 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0.4 0.7 5.0 12.7 7.5 0.3 0 0 0 0.7 1.0 0.2 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0
Other Current Assets 5.1 8.7 0.1 245.0 0.9 1.1 5.0 16.2 15.8 5.7 0 1.2 0 0
Total Current Assets 534.6 338.6 150.1 535.3 72.1 64.4 62.1 61.2 50.7 41.7 10.6 7.8 26.8 0.1
Non-Current Assets
Property, Plant & Equipment 16.1 5.9 4.8 4.1 2.6 0.9 1.2 2.0 2.9 0.1 0.5 5.4 0.0 0
Goodwill 1.5 1.5 1.5 1.5 1.5 1.5 1.2 2.4 3.5 0.8 0 0 0 0
Intangible Assets 0 0 0 0 7.7 8.5 7.7 13.9 20.9 4.3 7.2 6.9 0.0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 5.3 2.0 4.2 0.5 0.1 0 3.3 0 (0.0) 0 (9.7) (3.9) (26.7) 0
Total Non-Current Assets 22.9 9.4 10.5 6.1 11.9 10.9 13.3 18.3 27.4 5.3 7.8 12.3 0.0 0
Total Assets 557.5 348.1 160.6 541.4 84.0 75.3 75.5 79.5 78.1 47.0 18.4 20.1 26.9 0.1
Current Liabilities
Account Payables 15.1 3.7 2.1 0.3 3.2 4.5 3.4 5.8 12.5 1.1 0.2 1.0 0.0 0
Short-Term Debt 0 0 0 16.1 0 0 0.6 0 0 0 0 0.2 0 0
Deferred Revenue 0 0 0 0 5.9 6.1 1.2 0 0 0 0 0 0 0
Other Current Liabilities 12.8 11.0 4.9 5.1 3.7 1.3 0.0 10.9 20.0 12.2 1.4 0.8 0.3 0.0
Total Current Liabilities 54.2 33.3 16.1 31.6 19.0 14.6 9.9 17.2 32.5 13.6 1.8 2.7 0.4 0.0
Non-Current Liabilities
Long-Term Debt 0 0 79.1 403.1 0 0 0 0 0 0 0 1.7 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 1.6 2.2 3.4 0.7 1.5 1.5 0 0
Other Non-Current Liabilities 1.4 1.3 1.2 1.2 2.1 1.8 2.1 3.3 8.1 7.5 1.9 1.9 0 0
Total Non-Current Liabilities 14.3 4.1 83.0 406.6 3.3 2.3 4.4 6.6 50.0 37.7 3.4 5.1 0 0
Total Liabilities 68.5 37.4 99.1 438.2 22.3 16.9 14.3 23.7 82.6 51.3 5.2 7.8 0.4 0.0
Stockholders' Equity
Common Stock 5.8 5.9 5.6 1.7 0.7 0.6 0.5 2.1 1.0 0.8 11.0 8.1 5.9 0.0
Retained Earnings (1,702.6) (970.6) (786.0) (308.4) (222.0) (154.9) (119.5) (99.8) (132.9) (92.2) (43.9) (52.8) (0.1) (0.0)
Accumulated Other Comprehensive Income (1.9) (1.8) (1.9) (1.5) (1.6) (2.8) (3.6) 0 0 0 (5.2) (3.2) (0.0) 0
Total Stockholders' Equity 489.0 310.6 61.5 103.2 61.7 58.4 61.1 55.8 (4.5) (4.4) 13.2 12.3 26.5 0.1
Total Liabilities & Equity 557.5 348.1 160.6 541.4 84.0 75.3 75.5 79.5 78.1 47.0 18.4 20.1 26.9 0.1
Debt Metrics
Total Debt 15.5 5.8 84.0 422.9 2.1 0.3 0.7 0 0 0 0 1.9 0 0
Net Debt (151.7) (78.0) 27.4 138.7 (51.2) (48.4) (49.3) (35.2) (28.5) (35.1) (9.7) (2.0) (26.7) (0.1)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003
Operating Activities
Net Income (801.2) (176.9) (486.6) (64.2) (65.7) (38.7) (23.9) 10.9 (33.9) (32.1) (3.2) (0.5) (0.0)
Depreciation & Amortization 0.1 0.1 0.2 1.0 1.8 1.5 1.4 2.0 0.6 0.1 0.1 0.0 0
Stock-Based Compensation 543.6 40.7 11.2 9.7 9.5 1.3 0.5 6.3 2.3 1.7 0 0 0
Change in Working Capital 23.3 12.4 (0.4) 8.0 (0.0) 0.5 1.0 (54.9) 6.9 39.8 0.3 0.2 0.0
Other Non-Cash Items (5.4) 10.1 415.0 11.5 0.6 0.1 (6.0) 0.6 3.5 5.7 (0.1) 0 0.0
Operating Cash Flow (239.7) (113.6) (60.7) (33.9) (53.8) (35.3) (15.6) (35.1) (20.6) 15.2 (2.5) (0.3) (0.0)
Investing Activities
Capital Expenditure (0.5) (0.1) (0.1) (0.5) (0.2) (0.3) (0.3) (0.2) (0.7) (0.1) (2.5) (0.0) 0
Acquisitions 0 0 0 0 0 0 0 (0.2) (6.8) 0 0 0 0
Purchases of Investments (359.9) (543.4) (254.0) 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 231.1 391.4 164.7 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 (12.0) (375.7) 0 0 0 0.1 (0.0) (0.2) 0.0 4.8 (25.6) 0
Investing Cash Flow (129.4) (164.1) (465.1) (0.5) (0.2) (0.3) (0.1) (0.3) (7.4) (0.1) 2.4 (25.6) 0
Financing Activities
Net Debt Issuance 0 (79.9) (19.5) 423.9 0 0 0 (0.4) (0.2) 0.0 1.4 0 0.0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 (0.5) (0.1) (0.1) 0.4 (4.7) (1.2) (1.5) 0.5 (0.0) 0 0.0
Financing Cash Flow 458.3 304.6 68.5 505.6 57.8 37.1 33.1 44.5 19.5 0.5 1.3 26.5 0.2
Cash Position
Net Change in Cash 89.4 27.0 (456.8) 470.2 4.0 1.9 6.8 6.8 (11.3) 14.7 (20.0) (25.6) 0.2
Cash at Beginning 78.1 57.1 513.3 58.5 49.2 46.9 22.3 28.5 39.7 20.4 21.2 26.1 (0.0)
Cash at End 167.4 84.1 56.5 528.7 53.2 48.8 50.0 35.2 28.5 35.1 1.2 0.5 0.1
Free Cash Flow (240.2) (113.7) (60.8) (34.4) (54.0) (35.6) (15.8) (35.3) (21.3) 15.1 (5.0) (0.4) (0.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Income Statement
Revenue 0 0 0 0.6 1.3 0.6 0.6 57.1 14.2 2.4 1.3 1.9 2.3 2.9 1.8 1.2 0.3 0.3 6.0 2.0 0.9 0.2 0.0
Gross Profit 0 0 0 0.6 1.3 0.6 0.6 56.4 14.2 2.4 1.3 1.9 1.8 1.9 1.6 1.2 (2.1) 0.3 0.1 1.4 0.5 0.0 0
Operating Income (1,094.4) (180.5) (478.2) (59.6) (63.7) (38.9) (22.6) 5.4 (25.8) (24.9) (20.3) (12.2) (6.7) (4.6) (4.7) (9.4) (9.2) (19.2) (23.4) (8.6) (3.2) (0.5) (0.0)
Net Income (1,079.6) (176.8) (482.4) (65.2) (65.5) (38.5) (24.0) 10.9 (20.2) (21.4) (24.3) (17.1) (6.1) (6.7) (4.2) (7.4) (5.3) (32.3) (20.1) (5.9) (1.9) (0.1) (0.0)
EPS (Diluted) -1.44 -0.25 -0.78 -0.34 -0.71 -0.56 -0.73 0.11 -0.31 -0.35 -0.34 -0.31 -0.34 -0.42 -0.36 -0.19 -0.13 -0.60 -0.42 -0.16 -0.06 -0.00 -0.00
Balance Sheet
Cash & Equivalents 167.2 83.8 56.5 284.2 53.2 48.8 50.0 35.2 28.5 35.1 9.7 3.9 26.7 0.1
Total Assets 557.5 348.1 160.6 541.4 84.0 75.3 75.5 79.5 78.1 47.0 18.4 20.1 26.9 0.1
Total Debt 15.5 5.8 84.0 422.9 2.1 0.3 0.7 0 0 0 0 1.9 0 0
Stockholders' Equity 489.0 310.6 61.5 103.2 61.7 58.4 61.1 55.8 (4.5) (4.4) 13.2 12.3 26.5 0.1
Cash Flow
Operating Cash Flow (239.7) (113.6) (60.7) (33.9) (53.8) (35.3) (15.6) (35.1) (20.6) 15.2 (2.5) (0.3) (0.0)
Capital Expenditure (0.5) (0.1) (0.1) (0.5) (0.2) (0.3) (0.3) (0.2) (0.7) (0.1) (2.5) (0.0) 0
Free Cash Flow (240.2) (113.7) (60.8) (34.4) (54.0) (35.6) (15.8) (35.3) (21.3) 15.1 (5.0) (0.4) (0.0)